Pharmaceutical Compounding: Sodium Phosphate, Ammonium Chloride, and Sulfa Drugs

0.0(0)
studied byStudied by 0 people
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/57

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

58 Terms

1
New cards

Product Name (Exp. 1)

Sodium Phosphate Oral Solution

2
New cards

Formula of Active Ingredient (Exp. 1)

Na3PO4

3
New cards

Molecular Weight of Sodium Phosphate

163.94 g/mol

4
New cards

Physical Properties of Sodium Phosphate

Boiling Point: 373 K / Melting Point: 1856 K

5
New cards

Therapeutic Use (Exp. 1)

Saline Laxative for constipation & colonoscopy prep.

6
New cards

Mechanism of Action (Exp. 1)

Increases fluid in the small intestine.

7
New cards

Onset of Action (Exp. 1)

30 minutes to 6 hours.

8
New cards

Warning (Exp. 1)

Do not use in children younger than 5 years old.

9
New cards

Adverse Events (Exp. 1)

GI issues, dizziness, weakness, thirst, chest pain, headache.

10
New cards

Formulation - Sodium Phosphate

22.20 g

11
New cards

Formulation - Citric Acid (Exp. 1)

10.40 g

12
New cards

Formulation - Glycerin (Exp. 1)

10.00 mL

13
New cards

Formulation - Sodium Benzoate

0.12 g

14
New cards

Compounding Step 1 & 2 (Exp. 1)

Heat 60mL water to boiling, then dissolve Sodium Phosphate with Citric Acid.

15
New cards

Compounding Step 3, 4, 5 (Exp. 1)

Remove from heat, mix in glycerin, then dissolve sodium benzoate.

16
New cards

Packaging (Exp. 1)

Fill into a clean, calibrated, 60 mL amber Boston-round bottle.

17
New cards

Final Product Characteristics (Exp. 1)

Clear, colorless liquid with a saline taste.

18
New cards

Specific Gravity (Exp. 1)

1.39 @ 25 °C

19
New cards

Key Disadvantage of Solutions

Prone to microbial contamination and have a shorter shelf life.

20
New cards

Product Name (Exp. 2)

Ammonium Chloride Syrup

21
New cards

Formula of Active Ingredient (Exp. 2)

NH4Cl

22
New cards

Therapeutic Use (Exp. 2)

Expectorant

23
New cards

Mechanism of Action (Exp. 2)

Irritative action on bronchial mucosa causes production of respiratory fluid.

24
New cards

Pharmacodynamics of Ammonium Chloride

Systemic acidifier; converted to urea in the liver, liberating H+ ions.

25
New cards

Formulation - Ammonium Chloride

1.50 g

26
New cards

Formulation - Sodium Citrate (Exp. 2)

2.50 g

27
New cards

Formulation - Citric Acid (Exp. 2)

0.80 g

28
New cards

Formulation - Methyl Paraben (Exp. 2)

0.12 g

29
New cards

Formulation - Glycerin (Exp. 2)

7.5 mL

30
New cards

Formulation - Ethyl Alcohol, 95%

7.5 mL

31
New cards

Formulation - Lemon Oil

0.03 mL

32
New cards

Formulation - Simple Syrup (Exp. 2)

22.5 mL

33
New cards

Prepare simple syrup

Dissolve 85g of sucrose in 40mL boiling water.

34
New cards

Compounding Step 2 & 3 (Exp. 2)

Dissolve active ingredients in heated water; separately dissolve preservative.

35
New cards

Compounding Step 4, 5, 6 (Exp. 2)

Incorporate flavor/glycerin into syrup; add preservative to actives; combine mixtures.

36
New cards

Final Compounding Steps (Exp. 2)

Gradually add alcohol, add water to final volume, and filter.

37
New cards

Packaging (Exp. 2)

Fill into a clean, sterilized, light-resistant 60 mL amber Boston-round bottle.

38
New cards

Examples of Preservatives for Syrups

Benzoic acid, Methyl paraben, Sodium benzoate.

39
New cards

Role of Glycerin in Syrups

Acts as a co-solvent and humectant.

40
New cards

Product Name (Exp. 3)

Sulfadiazine-Sulfamerazine-Sulfamethazine Oral Suspension

41
New cards

Therapeutic Use (Exp. 3)

Antimicrobial.

42
New cards

Primary Objective (Exp. 3)

Manufacture by Dispersion method using a Homogenizer, per cGMP standards.

43
New cards

Physical Properties of Sulfamethazine

White/yellowish crystals, darkens on light exposure, melts at 197-200 °C.

44
New cards

Solubility of Sulfamethazine

Sparingly soluble in acetone.

45
New cards

Formulation - All 3 Sulfa Drugs

2.12 g EACH of Sulfadiazine, Sulfamerazine, and Sulfamethazine.

46
New cards

Formulation - Veegum

0.83 g.

47
New cards

Formulation - Sodium Citrate (Exp. 3)

0.67 g.

48
New cards

Formulation - Simple Syrup (Exp. 3)

20 mL.

49
New cards

Formulation - Methyl Paraben (Exp. 3)

0.17 g.

50
New cards

Equipment Unique to Exp. 3

Mortar and Pestle; Colloid Mill/Homogenizer.

51
New cards

Compounding Step 2 & 3 (Exp. 3)

Suspend Veegum in simple syrup; stir in sodium citrate and flavor.

52
New cards

Compounding Step 4 & 5 (Exp. 3)

Pre-mix dry sulfa powders in a mortar; gradually incorporate into syrup mixture.

53
New cards

Crucial Compounding Step (Exp. 3)

Pass the bulk suspension through the homogenizer several times.

54
New cards

Result of Homogenization

A homogenous, creamy, and viscous suspension is produced.

55
New cards

Packaging (Exp. 3)

Fill into a 120 mL wide-mouthed flint (clear) Boston-round bottle.

56
New cards

Desirable Properties of a Suspension

Pours freely, delivers homogenous doses, is easily resuspended by shaking.

57
New cards

Suspending Agents Used (Exp. 3)

Veegum (main agent) and Sodium Citrate (stabilizer).

58
New cards

Examples of Other Suspending Agents

Bentonite.